D. E. Shaw & Co., Inc. - ANIKA THERAPEUTICS INC ownership

ANIKA THERAPEUTICS INC's ticker is ANIK and the CUSIP is 035255108. A total of 122 filers reported holding ANIKA THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.01 and the average weighting 0.2%.

Quarter-by-quarter ownership
D. E. Shaw & Co., Inc. ownership history of ANIKA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$3,578,171
-4.1%
192,065
+33.7%
0.00%0.0%
Q2 2023$3,732,728
-6.0%
143,677
+3.9%
0.00%0.0%
Q1 2023$3,971,028
-7.9%
138,267
-5.1%
0.00%
-20.0%
Q4 2022$4,310,530
+19.1%
145,626
-4.2%
0.01%
+25.0%
Q3 2022$3,618,000
-15.9%
152,028
-21.1%
0.00%
-20.0%
Q2 2022$4,302,000
+0.6%
192,760
+13.1%
0.01%
+25.0%
Q1 2022$4,278,000
-26.2%
170,389
+5.4%
0.00%
-20.0%
Q4 2021$5,793,000
-23.5%
161,675
-9.1%
0.01%
-28.6%
Q3 2021$7,571,000
-9.3%
177,882
-7.7%
0.01%0.0%
Q2 2021$8,347,000
+6.4%
192,816
+0.2%
0.01%
-12.5%
Q1 2021$7,847,000
+10.5%
192,373
+22.6%
0.01%
+33.3%
Q4 2020$7,101,000
+19.8%
156,895
-6.3%
0.01%0.0%
Q3 2020$5,925,000
-11.4%
167,429
-5.6%
0.01%
-25.0%
Q2 2020$6,691,000
-2.4%
177,346
-25.3%
0.01%
-27.3%
Q1 2020$6,859,000
-58.7%
237,255
-25.9%
0.01%
-42.1%
Q4 2019$16,612,000
-25.9%
320,382
-21.5%
0.02%
-32.1%
Q3 2019$22,411,000
+33.6%
408,294
-1.2%
0.03%
+33.3%
Q2 2019$16,778,000
+78.1%
413,051
+32.6%
0.02%
+75.0%
Q1 2019$9,423,000
+73.6%
311,608
+93.0%
0.01%
+71.4%
Q4 2018$5,427,000
-20.6%
161,493
-0.4%
0.01%
-12.5%
Q3 2018$6,837,000
+134.4%
162,095
+77.8%
0.01%
+100.0%
Q2 2018$2,917,000
-45.7%
91,162
-15.7%
0.00%
-42.9%
Q1 2018$5,374,000
-21.6%
108,083
-15.0%
0.01%
-22.2%
Q4 2017$6,857,000
-8.7%
127,187
-1.8%
0.01%
-25.0%
Q3 2017$7,513,000
+33.0%
129,534
+13.2%
0.01%
+33.3%
Q2 2017$5,647,000
+65.3%
114,453
+45.6%
0.01%
+50.0%
Q1 2017$3,416,000
-18.2%
78,629
-7.8%
0.01%
-14.3%
Q4 2016$4,175,000
+49.6%
85,264
+46.2%
0.01%
+40.0%
Q3 2016$2,790,000
+62.3%
58,310
+82.0%
0.01%
+66.7%
Q2 2016$1,719,000
+22.6%
32,043
+2.2%
0.00%0.0%
Q1 2016$1,402,000
+567.6%
31,344
+513.1%
0.00%
Q1 2015$210,000
-42.6%
5,112
-35.3%
0.00%
Q2 2014$366,000
-88.9%
7,900
-90.1%
0.00%
-100.0%
Q1 2014$3,292,000
-21.7%
80,096
-27.3%
0.00%
-20.0%
Q4 2013$4,203,000
+154.9%
110,131
+60.0%
0.01%
+150.0%
Q3 2013$1,649,000
+455.2%
68,824
+293.9%
0.00%
+100.0%
Q2 2013$297,00017,4720.00%
Other shareholders
ANIKA THERAPEUTICS INC shareholders Q1 2023
NameSharesValueWeighting ↓
Euclidean Technologies Management, LLC 44,875$2,031,0002.14%
Parian Global Management LP 102,705$4,648,0001.16%
CAPITAL MANAGEMENT CORP /VA 93,035$4,211,0001.15%
Avidity Partners Management LP 731,000$33,085,0001.07%
Sio Capital Management, LLC 65,382$2,959,0000.61%
DIKER MANAGEMENT LLC 21,835$988,0000.50%
Archon Capital Management LLC 48,925$2,214,0000.38%
Caption Management, LLC 362,800$16,420,0000.37%
KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC 1,546,260$69,984,0000.20%
Boston Trust Walden Corp 378,167$17,116,0000.18%
View complete list of ANIKA THERAPEUTICS INC shareholders